Clinical Trial Detail

NCT ID NCT01093573
Title Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Brenda Cooper, MD
Indications

acute myeloid leukemia

Therapies

Azacitidine + Midostaurin

Age Groups: senior

No variant requirements are available.